Literature DB >> 27720608

Acetylation of VGLL4 Regulates Hippo-YAP Signaling and Postnatal Cardiac Growth.

Zhiqiang Lin1, Haidong Guo2, Yuan Cao3, Sylvia Zohrabian4, Pingzhu Zhou4, Qing Ma4, Nathan VanDusen4, Yuxuan Guo4, Jin Zhang4, Sean M Stevens4, Feng Liang5, Qimin Quan5, Pim R van Gorp6, Amy Li7, Cristobal Dos Remedios7, Aibin He8, Vassilios J Bezzerides4, William T Pu9.   

Abstract

Binding of the transcriptional co-activator YAP with the transcription factor TEAD stimulates growth of the heart and other organs. YAP overexpression potently stimulates fetal cardiomyocyte (CM) proliferation, but YAP's mitogenic potency declines postnatally. While investigating factors that limit YAP's postnatal mitogenic activity, we found that the CM-enriched TEAD1 binding protein VGLL4 inhibits CM proliferation by inhibiting TEAD1-YAP interaction and by targeting TEAD1 for degradation. Importantly, VGLL4 acetylation at lysine 225 negatively regulated its binding to TEAD1. This developmentally regulated acetylation event critically governs postnatal heart growth, since overexpression of an acetylation-refractory VGLL4 mutant enhanced TEAD1 degradation, limited neonatal CM proliferation, and caused CM necrosis. Our study defines an acetylation-mediated, VGLL4-dependent switch that regulates TEAD stability and YAP-TEAD activity. These insights may improve targeted modulation of TEAD-YAP activity in applications from cardiac regeneration to cancer.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hippo-YAP pathway; TEAD1; VGLL4; acetylation; cardiac; cardiomyocyte; degradation; necrosis; proliferation

Mesh:

Substances:

Year:  2016        PMID: 27720608      PMCID: PMC5121000          DOI: 10.1016/j.devcel.2016.09.005

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  41 in total

1.  Vgl-4, a novel member of the vestigial-like family of transcription cofactors, regulates alpha1-adrenergic activation of gene expression in cardiac myocytes.

Authors:  Hsiao-Huei Chen; Steven J Mullett; Alexandre F R Stewart
Journal:  J Biol Chem       Date:  2004-05-12       Impact factor: 5.157

2.  YAP Drives Growth by Controlling Transcriptional Pause Release from Dynamic Enhancers.

Authors:  Giorgio G Galli; Matteo Carrara; Wei-Chien Yuan; Christian Valdes-Quezada; Basanta Gurung; Brian Pepe-Mooney; Tinghu Zhang; Geert Geeven; Nathanael S Gray; Wouter de Laat; Raffaele A Calogero; Fernando D Camargo
Journal:  Mol Cell       Date:  2015-10-01       Impact factor: 17.970

3.  A novel acetylation cycle of transcription co-activator Yes-associated protein that is downstream of Hippo pathway is triggered in response to SN2 alkylating agents.

Authors:  Shoji Hata; Jun Hirayama; Hiroaki Kajiho; Kentaro Nakagawa; Yutaka Hata; Toshiaki Katada; Makoto Furutani-Seiki; Hiroshi Nishina
Journal:  J Biol Chem       Date:  2012-04-27       Impact factor: 5.157

4.  Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.

Authors:  Mei Xin; Yuri Kim; Lillian B Sutherland; Xiaoxia Qi; John McAnally; Robert J Schwartz; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Sci Signal       Date:  2011-10-25       Impact factor: 8.192

5.  L-trans-Epoxysuccinyl-leucylamido(4-guanidino)butane (E-64) and its analogues as inhibitors of cysteine proteinases including cathepsins B, H and L.

Authors:  A J Barrett; A A Kembhavi; M A Brown; H Kirschke; C G Knight; M Tamai; K Hanada
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

6.  Direct observation of individual endogenous protein complexes in situ by proximity ligation.

Authors:  Ola Söderberg; Mats Gullberg; Malin Jarvius; Karin Ridderstråle; Karl-Johan Leuchowius; Jonas Jarvius; Kenneth Wester; Per Hydbring; Fuad Bahram; Lars-Gunnar Larsson; Ulf Landegren
Journal:  Nat Methods       Date:  2006-10-29       Impact factor: 28.547

7.  YAP1 increases organ size and expands undifferentiated progenitor cells.

Authors:  Fernando D Camargo; Sumita Gokhale; Jonathan B Johnnidis; Dongdong Fu; George W Bell; Rudolf Jaenisch; Thijn R Brummelkamp
Journal:  Curr Biol       Date:  2007-11-01       Impact factor: 10.834

8.  Cardiac-specific YAP activation improves cardiac function and survival in an experimental murine MI model.

Authors:  Zhiqiang Lin; Alexander von Gise; Pingzhu Zhou; Fei Gu; Qing Ma; Jianming Jiang; Allan L Yau; Jessica N Buck; Katryna A Gouin; Pim R R van Gorp; Bin Zhou; Jinghai Chen; Jonathan G Seidman; Da-Zhi Wang; William T Pu
Journal:  Circ Res       Date:  2014-05-15       Impact factor: 17.367

9.  Yap1 is required for endothelial to mesenchymal transition of the atrioventricular cushion.

Authors:  Hui Zhang; Alexander von Gise; Qiaozhen Liu; Tianyuan Hu; Xueying Tian; Lingjuan He; Wenjuan Pu; Xiuzhen Huang; Liang He; Chen-Leng Cai; Fernando D Camargo; William T Pu; Bin Zhou
Journal:  J Biol Chem       Date:  2014-05-15       Impact factor: 5.157

10.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Authors:  Francesca Zanconato; Mattia Forcato; Giusy Battilana; Luca Azzolin; Erika Quaranta; Beatrice Bodega; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2015-08-10       Impact factor: 28.824

View more
  44 in total

1.  Loss of VGLL4 suppresses tumor PD-L1 expression and immune evasion.

Authors:  Ailing Wu; Qingzhe Wu; Yujie Deng; Yuning Liu; Jinqiu Lu; Liansheng Liu; Xiaoling Li; Cheng Liao; Bin Zhao; Hai Song
Journal:  EMBO J       Date:  2018-11-05       Impact factor: 11.598

Review 2.  Redirecting cardiac growth mechanisms for therapeutic regeneration.

Authors:  Ravi Karra; Kenneth D Poss
Journal:  J Clin Invest       Date:  2017-02-01       Impact factor: 14.808

3.  Validation of Osteogenic Properties of Cytochalasin D by High-Resolution RNA-Sequencing in Mesenchymal Stem Cells Derived from Bone Marrow and Adipose Tissues.

Authors:  Rebekah M Samsonraj; Christopher R Paradise; Amel Dudakovic; Buer Sen; Asha A Nair; Allan B Dietz; David R Deyle; Simon M Cool; Janet Rubin; Andre J van Wijnen
Journal:  Stem Cells Dev       Date:  2018-07-23       Impact factor: 3.272

Review 4.  Non-sarcomeric causes of heart failure: a Sydney Heart Bank perspective.

Authors:  C G Dos Remedios; A Li; S Lal
Journal:  Biophys Rev       Date:  2018-07-18

5.  Expression Profiling of Clinical Specimens Supports the Existence of Neural Progenitor-Like Stem Cells in Basal Breast Cancers.

Authors:  Alex Panaccione; Yan Guo; Wendell G Yarbrough; Sergey V Ivanov
Journal:  Clin Breast Cancer       Date:  2017-01-27       Impact factor: 3.225

6.  Hippo Deficiency Leads to Cardiac Dysfunction Accompanied by Cardiomyocyte Dedifferentiation During Pressure Overload.

Authors:  Shohei Ikeda; Wataru Mizushima; Sebastiano Sciarretta; Maha Abdellatif; Peiyong Zhai; Risa Mukai; Nadezhda Fefelova; Shin-Ichi Oka; Michinari Nakamura; Dominic P Del Re; Iain Farrance; Ji Yeon Park; Bin Tian; Lai-Hua Xie; Mohit Kumar; Chiao-Po Hsu; Sakthivel Sadayappan; Hiroaki Shimokawa; Dae-Sik Lim; Junichi Sadoshima
Journal:  Circ Res       Date:  2019-01-18       Impact factor: 17.367

Review 7.  An overview of signaling pathways regulating YAP/TAZ activity.

Authors:  Boon Chin Heng; Xuehui Zhang; Dominique Aubel; Yunyang Bai; Xiaochan Li; Yan Wei; Martin Fussenegger; Xuliang Deng
Journal:  Cell Mol Life Sci       Date:  2020-08-03       Impact factor: 9.261

Review 8.  Cardiomyocyte Maturation: New Phase in Development.

Authors:  Yuxuan Guo; William T Pu
Journal:  Circ Res       Date:  2020-04-09       Impact factor: 17.367

9.  Tead1 is essential for mitochondrial function in cardiomyocytes.

Authors:  Ruya Liu; Rajaganapathi Jagannathan; Lingfei Sun; Feng Li; Ping Yang; Jeongkyung Lee; Vinny Negi; Eliana M Perez-Garcia; Sruti Shiva; Vijay K Yechoor; Mousumi Moulik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-06-05       Impact factor: 4.733

Review 10.  VGLL4 is a transcriptional cofactor acting as a novel tumor suppressor via interacting with TEADs.

Authors:  Xiaochong Deng; Lin Fang
Journal:  Am J Cancer Res       Date:  2018-06-01       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.